Making the cut

What are likely to be the top 10 drug launches of 2017?  2016 was an "unusually slow year" for drug approvals, according to US industry website Fierce Pharma.  However, analysts are still predicting a range of new 'blockbuster' drug launches. Heading the list, according to EP Vantage’s 2017 preview, which ranks the year’s rollouts by